You are here

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Phoenix, Arizona, 85013 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Type 2 Diabetes Mellitus
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-70 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients with type 2 diabetes mellitus who are not taking any treatment or are taking
metformin (with no change in the treatment, including dose, over the past 2 months).
Subjects previously treated with a sulfonylurea in combination with metformin may be
eligible if switched over to metformin only for a minimum of 4 weeks before dosing.

- Male and/or female subjects (females will be women of non-childbearing potential)
between the ages of 18 and 70 years, inclusive.

- Body Mass Index (BMI) of approximately 22 to 40 kg/m2

- Fasting C-peptide test result must be >0.4 nmol/L.

- HbA1c ≥7% and ≤11%. If the subject requires to be washed off a sulfonylurea, the HbA1c
limits will be ≥7% and ≤9.5%.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Screening fasting blood glucose, ?60 or ?270 mg/dL. One repeat screening fasting blood
glucose will be allowed.

- Previous treatment with an approved or investigational GLP-1 mimetic.

- Have a known allergy to yeast, yeast-derived or yeast containing products.

NCT00637338
Pfizer
Terminated
Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Coronary Arteriosclerosis, Type 2 Diabetes Mellitus, Cerebrovascular Accident, Dyslipidemia, Peripheral Vascular Disease
NCT00442845
All Genders
18+
Years
Multiple Sites
Type 2 Diabetes Mellitus
NCT01792635
All Genders
18+
Years
Chula Vista, California

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now